Ostatní
Návod 
Legend Biotech Corporation
LEGN
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
2.9B
Obrat
1B
Zisk
0B
Aktiva
2B
Dluh
0B
ROE
-24%
ROA
-14%
PE
-11
PS
3
Cena 1R
20-45
⌀ Cena
32.10
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
10-03-2026
Poslední dividenda
Profil
Legend Biotech Corporation, biofarmaceutická společnost v klinickém stadiu, se prostřednictvím svých dceřiných společností zabývá objevováním a vývojem nových buněčných terapií pro onkologii a další indikace ve Spojených státech, Číně a mezinárodně. LCAR- B38M je chimerický antigenní receptor pro léčbu mnohočetného myelomu (MM), stejně jako srovnání léčby se standardní trojkombinovanou terapií relimidního mnohočetného myelomu. Společnost má také portfolio kandidátů na autologní léčivé přípravky v raném stadiu, které jsou v klinických studiích fáze I pro léčbu rakoviny žaludku a lymfomu T buněk. Kromě toho vyvíjí kandidáty na přípravky CAR-T zaměřené na CD20/CD22/CD19 pro léčbu non-hodgkinsova lymfomu, difuzního velkobuněčného lymfomu B a akutní lymfoblastické leukémie. Dále má společnost produktové kandidáty v raném preklinickém a klinickém vývoji pro léčbu solidních nádorů i infekčních onemocnění. Má spolupráci a licenční smlouvu s Janssen Biotech, Inc. na vývoji a komercializaci ciltacabtagene autoleucel. Legend Biotech Corporation byla založena v roce 2014 a sídlí v Somersetu v New Jersey. Legend Biotech Corporation je dceřinou společností Genscript Biotech Corporation.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
2600
Založení
2020-06-05
Podobné společnosti
$ 82.78
- $ 1.07
$ 21.56
- $ 0.35
$ 72.35
+ $ 4.10
$ 14.58
- $ 0.21
$ 29.44
+ $ 0.49
$ 38.12
- $ 0.13
$ 30.79
+ $ 0.55
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 1,030.1 | 1,031.6 | 627.2 | 285.1 | 117.0 | 89.8 | 75.7 | 57.3 | 49.1 | |
| Cost of Revenues | 408.7 | 409.2 | 234.6 | 144.2 | 65.4 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 621.4 | 622.4 | 392.7 | 140.9 | 51.6 | 89.8 | 75.7 | 57.3 | 49.1 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 307.6 | 272.3 | 255.1 | 195.1 | 186.5 | 160.2 | 186.5 | 94.0 | 79.5 | 96.0 | |
| Cost of Revenues | 124.0 | 115.3 | 98.0 | 71.3 | 73.9 | 55.5 | 50.5 | 54.7 | 37.8 | 43.5 | |
| Gross Profit | 183.6 | 157.0 | 157.1 | 123.7 | 112.6 | 104.7 | 136.1 | 39.3 | 41.7 | 52.5 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 382.2 | 335.6 | 313.3 | 232.2 | 161.9 | 60.6 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 200.9 | 174.0 | 149.5 | 72.7 | 32.4 | 3.9 | |
| Depreciation & Amortization | 29.0 | 29.1 | 23.4 | 20.5 | 18.4 | 13.9 | 9.9 | 5.3 | 1.7 | |
| Total Operating Expenses | 757.2 | 759.3 | 695.9 | 140.9 | 509.7 | 462.8 | 304.9 | 192.6 | 64.2 | |
| Operating Income | -135.8 | -136.9 | -303.2 | -439.5 | -455.8 | -393.0 | -313.3 | -130.9 | -1.5 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 105.7 | 95.9 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 57.0 | 49.2 | ||
| Depreciation & Amortization | 12.1 | 5.9 | 5.9 | 5.2 | 6.8 | 5.5 | 5.4 | 5.7 | 5.4 | 5.2 | ||
| Total Operating Expenses | 203.4 | 200.5 | 178.9 | 174.4 | 187.0 | 174.8 | 178.0 | 157.1 | 162.7 | 144.9 | ||
| Operating Income | -19.8 | -43.5 | -21.9 | -50.6 | -74.4 | -70.1 | -42.0 | -117.9 | -121.1 | -67.0 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 40.1 | 40.2 | 61.2 | 54.5 | 8.2 | 1.0 | 2.9 | 4.6 | 6.2 | |
| Interest Expense | 21.5 | 21.5 | 21.6 | 21.8 | 10.8 | 0.9 | 4.2 | 0.2 | 0.1 | |
| Other Expense | -147.0 | -146.5 | 145.1 | -80.6 | 10.1 | 6.8 | 5.7 | 0.5 | 7.3 | |
| IBT | -282.8 | -283.3 | -158.1 | -520.1 | -445.7 | -386.2 | -307.6 | -130.4 | -1.6 | |
| Income Tax Expense | 14.2 | 14.2 | 18.9 | -1.9 | 0.6 | 0.0 | -4.1 | 2.6 | 1.2 | |
| Net Income | -297.0 | -297.6 | -177.0 | -518.3 | -446.3 | -386.2 | -303.5 | -133.0 | -2.8 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 7.9 | 9.7 | 10.5 | 12.1 | 13.7 | 16.6 | 17.0 | 13.9 | 17.3 | 18.4 | ||
| Interest Expense | 5.5 | 5.6 | 5.2 | 5.1 | 5.2 | 5.5 | 5.5 | 5.5 | 5.8 | 5.7 | ||
| Other Expense | 0.0 | 4.4 | -102.9 | -48.5 | 114.9 | -50.8 | 24.0 | 58.1 | -25.8 | 30.0 | ||
| IBT | -19.8 | -39.1 | -124.8 | -99.1 | 40.5 | -120.9 | -18.0 | -59.8 | -146.8 | -62.5 | ||
| Income Tax Expense | 11.2 | 0.6 | 0.6 | 1.8 | 14.2 | 4.4 | 0.2 | 0.0 | -2.0 | -0.3 | ||
| Net Income | -31.0 | -39.7 | -125.4 | -100.9 | 26.3 | -125.3 | -18.2 | -59.8 | -144.8 | -62.2 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-2.94 | $-2.81 | $-2.74 | $-2.57 | $-1.33 | $-0.03 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-2.94 | $-2.81 | $-2.74 | $-2.57 | $-1.33 | $-0.03 | |
| Shares Outstanding | 184.7 | 184.3 | 91.4 | 176.1 | 159.0 | 140.9 | 118.2 | 100.2 | 100.2 | |
| Diluted Shares Outstanding | 184.7 | 184.3 | 91.4 | 176.1 | 159.0 | 140.9 | 118.2 | 100.2 | 100.2 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.80 | $-0.34 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.80 | $-0.34 | ||
| Shares Outstanding | 184.7 | 180.4 | 184.1 | 183.8 | 91.4 | 91.4 | 91.3 | 91.0 | 181.9 | 181.8 | ||
| Diluted Shares Outstanding | 184.7 | 184.6 | 184.1 | 183.8 | 91.4 | 91.4 | 91.3 | 91.0 | 181.9 | 181.8 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 201.7 | 286.7 | 1,277.7 | 786.0 | 688.9 | 455.7 | 83.4 | 210.2 | |
| Short Term Investments | 1,090.6 | 835.9 | 31.0 | 239.6 | 193.5 | 50.0 | 75.6 | 6.0 | |
| Total Cash & ST Investments | 1,292.3 | 1,122.7 | 1,308.7 | 1,025.7 | 882.4 | 505.7 | 158.9 | 216.2 | |
| Accounts Receivable | 101.4 | 124.9 | 157.1 | 0.1 | 63.2 | 85.0 | 35.8 | 108.6 | |
| Inventory | 18.9 | 23.9 | 19.4 | 10.4 | 1.7 | 1.8 | 1.2 | 1.1 | |
| Other Current Assets | 12.3 | 12.4 | 12.6 | 1,099.1 | 1.4 | 580.7 | 11.3 | 1.1 | |
| Total Current Assets | 1,424.8 | 1,283.9 | 1,497.8 | 1,099.1 | 948.8 | 592.9 | 207.1 | 327.0 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 278.9 | 266.6 | 441.7 | 286.7 | 459.3 | 201.3 | 897.6 | 1,278.1 | 963.5 | 1,233.2 | |
| Short Term Investments | 713.7 | 701.0 | 563.7 | 835.9 | 753.1 | 1,090.6 | 404.8 | 31.0 | 460.4 | 281.6 | |
| Total Cash & ST Investments | 992.6 | 967.6 | 1,005.4 | 1,122.7 | 1,212.4 | 1,291.8 | 1,302.4 | 1,309.1 | 1,423.8 | 1,514.8 | |
| Accounts Receivable | 1.3 | 229.0 | 166.8 | 124.9 | 104.0 | 101.4 | 78.0 | 157.1 | 49.7 | 62.9 | |
| Inventory | 29.2 | 35.6 | 30.9 | 23.9 | 23.5 | 18.9 | 22.1 | 19.4 | 18.0 | 15.2 | |
| Other Current Assets | 218.9 | 17.7 | 15.6 | 12.4 | 10.1 | 12.7 | 11.3 | 12.6 | 17.3 | 20.0 | |
| Total Current Assets | 1,242.0 | 1,249.9 | 1,218.8 | 1,283.9 | 1,350.0 | 1,424.8 | 1,413.8 | 1,497.8 | 1,508.8 | 1,612.9 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 220.0 | 201.6 | 189.7 | 161.7 | 155.1 | 121.3 | 75.5 | 33.1 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -4.9 | 0.0 | 0.0 | |
| Intangible Assets | 147.3 | 174.2 | 4.1 | 3.4 | 4.7 | 7.7 | 5.1 | 0.0 | |
| Long-Term Investments | 4.4 | 4.4 | 4.4 | 0.0 | 4.7 | 0.0 | 0.0 | -1.2 | |
| Other Long-Term Assets | 146.1 | 6.1 | 152.4 | 66.8 | 5.1 | 4.0 | 0.0 | 1.2 | |
| Total Long-Term Assets | 373.4 | 386.2 | 350.8 | 231.8 | 169.6 | 128.1 | 80.6 | 102.1 | |
| Total Assets | 1,798.2 | 1,670.2 | 1,848.6 | 1,331.0 | 1,118.4 | 721.0 | 287.7 | 429.0 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 253.7 | 233.6 | 206.6 | 201.6 | 203.9 | 220.0 | 186.0 | 189.7 | 184.7 | 190.5 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -119.2 | |
| Intangible Assets | 0.0 | 200.8 | 184.7 | 174.2 | 175.5 | 147.3 | 169.5 | 155.3 | 140.0 | 121.6 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 4.4 | 4.5 | 4.4 | 4.4 | 4.6 | 4.3 | 4.2 | |
| Other Long-Term Assets | 217.2 | 5.7 | 5.6 | 6.1 | 1.9 | 1.6 | 1.4 | 152.4 | 1.5 | 1.4 | |
| Total Long-Term Assets | 470.9 | 440.0 | 396.9 | 386.2 | 385.8 | 373.4 | 361.3 | 350.8 | 330.5 | 317.8 | |
| Total Assets | 1,712.9 | 1,689.9 | 1,615.6 | 1,670.2 | 1,735.8 | 1,798.2 | 1,775.1 | 1,848.6 | 1,839.3 | 1,930.7 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 39.5 | 37.2 | 20.2 | 32.9 | 7.0 | 5.2 | 9.6 | 7.3 | |
| Short-Term Debt | 3.3 | 4.8 | 3.2 | 3.6 | 0.9 | 1.5 | 1.0 | 0.4 | |
| Other Current Liabilities | 176.6 | 164.2 | 132.9 | 260.9 | 211.4 | 99.2 | 70.9 | 111.2 | |
| Current Liabilities | 294.3 | 277.6 | 216.4 | 297.8 | 280.3 | 161.2 | 127.8 | 159.2 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 102.5 | 75.4 | 58.1 | 37.2 | 26.9 | 39.5 | 39.5 | 20.2 | 17.2 | 21.5 | |
| Short-Term Debt | 150.2 | 5.9 | 5.3 | 4.8 | 4.3 | 3.3 | 3.1 | 3.2 | 2.9 | 3.6 | |
| Other Current Liabilities | 180.9 | 138.8 | 110.7 | 164.2 | 162.9 | 167.7 | 133.0 | 132.8 | 143.5 | 162.7 | |
| Current Liabilities | 433.6 | 265.5 | 234.4 | 277.6 | 270.9 | 294.3 | 249.7 | 216.4 | 175.2 | 201.4 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 291.6 | 345.8 | 325.5 | 281.0 | 122.1 | 1.9 | 5.1 | 3.9 | |
| Capital Leases | 44.0 | 49.4 | 47.3 | 23.6 | 2.5 | 3.4 | 6.1 | 4.3 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 1.9 | 2.1 | 0.0 | -213.2 | |
| Total Liabilities | 632.6 | 629.6 | 597.2 | 586.7 | 647.2 | 440.8 | 410.6 | 420.4 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 260.0 | 382.0 | 357.5 | 345.8 | 342.2 | 335.6 | 331.6 | 325.5 | 317.6 | 315.1 | |
| Capital Leases | 95.4 | 77.6 | 57.1 | 49.4 | 50.0 | 47.4 | 48.3 | 44.2 | 44.6 | 48.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 44.2 | -6.8 | -7.0 | |
| Total Liabilities | 701.7 | 654.4 | 597.9 | 629.6 | 619.7 | 639.2 | 611.0 | 589.9 | 499.7 | 523.6 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -1,562.7 | -1,661.7 | -1,484.7 | -966.5 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Comprehensive Income | -14.2 | -68.2 | 98.9 | 744.3 | 471.2 | 280.2 | -122.9 | 8.6 | |
| Total Common Equity | 1,159.0 | 1,040.5 | 1,251.4 | 744.3 | 471.2 | 280.3 | -122.9 | 8.6 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -1,927.7 | -1,888.0 | -1,762.7 | -1,661.7 | -1,688.0 | -1,562.7 | -1,544.5 | -1,484.7 | -1,339.9 | -1,277.7 | |
| Comprehensive Income | 200.6 | 116.8 | -7.4 | -68.2 | 47.7 | -14.2 | -3.7 | 98.9 | 1.0 | 1,407.0 | |
| Total Common Equity | 1,011.3 | 1,035.5 | 1,017.7 | 1,040.5 | 1,116.1 | 1,159.0 | 1,164.1 | 1,251.4 | 1,339.6 | 1,407.0 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 338.9 | 350.6 | 328.7 | 284.5 | 123.0 | 3.4 | 6.1 | 4.3 | |
| Book Value | 1,165.6 | 1,040.5 | 1,251.4 | 744.3 | 471.2 | 280.3 | -122.9 | 8.6 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 1,011.3 | 1,035.5 | 1,017.7 | 1,040.5 | 1,116.1 | 1,159.0 | 1,164.1 | 1,251.4 | 1,339.6 | 1,407.0 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -285.3 | -297.6 | -158.1 | -518.3 | -445.7 | -386.2 | -307.6 | -130.4 | -1.6 | |
| Depreciation & Amortization | 21.6 | 29.0 | 23.4 | 20.5 | 18.4 | 13.9 | 9.9 | 5.3 | 1.7 | |
| Stock-Based Compensation | 65.4 | 0.0 | 68.9 | 47.7 | 34.3 | 20.2 | 4.8 | 1.3 | 0.7 | |
| Change Working Capital | 90.3 | -93.3 | 20.0 | -71.3 | 186.3 | 140.9 | -23.9 | 52.5 | 318.7 | |
| Change In Accounts Receivable | 3.0 | -132.9 | 93.8 | -99.0 | 50.3 | 24.6 | -45.0 | -3.8 | 207.6 | |
| Change In Accounts Payable | 17.9 | 44.5 | 14.1 | -12.7 | 25.9 | 1.8 | -4.3 | 2.0 | 3.2 | |
| Change In Inventories | -7.3 | -4.5 | -17.2 | -12.7 | -8.6 | 0.1 | -0.6 | 0.0 | -1.1 | |
| Other Non-cash Items | 51.1 | 261.5 | -98.2 | 128.2 | 6.6 | 187.7 | 84.6 | -4.4 | -6.1 | |
| Cash from Operations | -138.3 | 0.0 | 0.0 | -393.3 | -200.0 | -198.5 | -223.0 | -83.1 | 307.7 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -30.9 | -39.1 | -124.8 | -99.1 | 40.5 | -120.9 | -18.0 | -59.8 | -144.8 | -62.5 | |
| Depreciation & Amortization | 12.0 | 5.9 | 5.9 | 5.2 | 6.8 | 3.9 | 5.4 | 5.7 | 5.4 | 5.2 | |
| Stock-Based Compensation | 0.0 | 15.0 | 18.7 | 15.9 | 13.4 | 15.1 | 21.7 | 18.7 | 12.6 | 12.4 | |
| Change Working Capital | -31.2 | 77.0 | -36.6 | -73.6 | -80.1 | 2.0 | 3.0 | 94.0 | -11.6 | -1.8 | |
| Change In Accounts Receivable | -138.4 | 25.8 | -26.2 | 5.9 | -5.6 | 12.4 | -9.8 | 96.7 | -99.1 | 15.0 | |
| Change In Accounts Payable | -15.9 | 24.3 | 16.5 | 19.5 | 7.5 | -12.8 | -2.0 | 22.8 | 3.0 | -4.4 | |
| Change In Inventories | -3.9 | 5.4 | -2.8 | -3.2 | -6.3 | -5.1 | -1.4 | -4.5 | -5.0 | -2.8 | |
| Other Non-cash Items | -55.5 | -30.1 | 123.8 | 47.8 | -62.7 | 24.1 | -13.8 | -43.2 | 169.6 | -12.9 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -93.2 | -60.8 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -74.2 | -67.6 | -14.1 | -20.1 | -22.3 | -47.1 | -49.8 | -39.2 | -21.0 | |
| Acquisitions | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 3.2 | 4.0 | -0.5 | 0.0 | |
| Investments | -6,775.9 | -4,554.9 | -2,712.2 | -4,863.1 | -655.0 | -378.0 | -72.7 | -390.4 | -6.0 | |
| Sales of Investment | 5,977.9 | 5,334.0 | 1,930.2 | 5,067.7 | 613.6 | 230.1 | 98.3 | 320.9 | 0.0 | |
| Other Investing Activities | -59.0 | 0.0 | 0.0 | -91.7 | -14.7 | -3.2 | -4.0 | 50.5 | -75.2 | |
| Cash from Investing | -897.6 | 0.0 | 0.0 | 92.8 | -78.3 | -195.0 | -24.2 | -58.7 | -102.3 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -20.9 | -5.0 | -9.2 | -2.0 | -2.4 | -2.1 | -3.4 | -6.2 | -25.4 | -5.5 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | |
| Investments | -8.6 | -387.4 | -4,050.0 | -100.0 | -313.4 | -54.1 | -1,472.5 | -872.3 | -1,914.5 | -2,516.7 | |
| Sales of Investment | 669.7 | 381.1 | 3,900.0 | 374.0 | 233.2 | 400.6 | 797.4 | 498.9 | 2,344.1 | 2,339.4 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.9 | -26.2 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 405.1 | -209.1 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -3.9 | 0.0 | 0.0 | -3.8 | -2.6 | -1.4 | -2.6 | -7.9 | -0.2 | |
| Debt Issued | 24.3 | 350.6 | 21.9 | 47.9 | 164.2 | 121.0 | -0.1 | 9.7 | 4.5 | |
| Issuance of Common Stock | 7.0 | 0.0 | 0.0 | 583.7 | 377.6 | 623.4 | 462.1 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 4.9 | 0.0 | 0.0 | 211.6 | 2.9 | 4.6 | 159.4 | 22.6 | 2.7 | |
| Cash from Financing | 3.7 | 0.0 | 0.0 | 791.5 | 378.0 | 626.7 | 618.9 | 14.7 | 2.5 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | -1.7 | |
| Debt Issued | 410.2 | 22.3 | 25.1 | 12.2 | 4.0 | 7.7 | 4.2 | 6.0 | 8.5 | 3.6 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.6 | 2.7 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.6 | 2.7 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.9 | 1.0 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -1,031.9 | 615.1 | -991.0 | 491.7 | 97.1 | 233.2 | 372.3 | -126.8 | 208.1 | |
| Closing Cash Balance | 201.7 | 901.9 | 286.7 | 1,277.7 | 786.0 | 688.9 | 455.7 | 83.4 | 210.2 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 622.9 | 12.3 | -175.1 | 155.0 | -172.5 | 258.0 | -696.3 | -380.1 | 314.2 | -269.7 | |
| Closing Cash Balance | 901.9 | 278.9 | 266.6 | 441.7 | 286.7 | 459.3 | 201.3 | 897.6 | 1,278.1 | 963.5 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -212.5 | -168.0 | -158.1 | -416.0 | -222.3 | -245.6 | -272.8 | -122.2 | 286.7 | |
| Real Free Cash Flow | -278.0 | -168.0 | -227.1 | -463.7 | -256.6 | -265.7 | -277.5 | -123.5 | 286.0 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -126.6 | 23.8 | -22.3 | -105.8 | -84.5 | -77.9 | -5.1 | 9.3 | -118.7 | -66.3 | |
| Real Free Cash Flow | -126.6 | 8.8 | -41.0 | -121.7 | -97.8 | -93.0 | -26.8 | -9.4 | -131.2 | -78.7 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -10.8 | 14.5 | -1.4 |
| P/S | 3.1 | 51.7 | 9.4 |
| P/B | 3.2 | 8.5 | 5.2 |
| P/FCF | -11.5 | -24.8 | -1.5 |
| Market cap | $2.9 | $7.1 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 23.9 % | 10.6 % | 0 % |
| Debt to Income | -138.1 % | 16.9 % | 0 % |
| Debt to Free cash flow | -146.3 % | -1268.1 % | 0 % |
| Interest expense percentage | -15.8 % | 6.2 % | 44.7 % |
| Current ratio | 2.9 | 3.9 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -29.4 % | 0.4 % | 0 % |
| ROA | -17.3 % | -24 % | 0 % |
| CapEx to Revenue | 2 % | 25.6 % | 0 % |
| RaD to Revenue | 0 % | 135 % | 0 % |
| ROEM | 396,183.7 | 56320.3 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 60.6 % | 72.2 % | 68.7 % |
| Operating margin | -20.9 % | -176.3 % | 35.5 % |
| Net margin | -26.4 % | -212.7 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 92.3 mil | 137.8 mil |
| Employee count | 2.6 tis | 1.5 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
